AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Oramed Pharmaceuticals Inc. Director's Dealing 2023

Apr 20, 2023

6965_rns_2023-04-20_527add31-c005-4bef-b1b1-8b0c49385aec.htm

Director's Dealing

Opens in your device viewer

_________ false


��	2 381
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008	14166
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	19/04/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-036877	Time of broadcast: 14:22 14:22

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	Form 4 - Josh Hexter

Form_4_-_Josh_Hexter_-_April_19_2023_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 21/02/2023
Address: Avenue of the Americas 01185 , New York 10036 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: [email protected] Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: DEROVAN NETANEL MOSHE Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Mamila 20 , Jerusalem 9414904 Telephone: 02-5660001 Facsimile: E-mail: [email protected] 1
USA